Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: ISRCTN05663421. We help you review the study, but cannot decide medical eligibility.
Not recruitingISRCTN05663421
A pilot study on a sensor-based Social Information Monitoring for Patients with Bipolarity (SIMBA) via smart phones
A short description of this study’s research objective has not yet been verified.
Research studyAges 18+Germany
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- Germany
- Compensation
- Payment and expense reimbursement have not been verified.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Investment & Development Bank of Lower Saxony Nbank (Germany)
- Sponsor type
- Unknown or unclear
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Not clearly listed
- Locations
- Germany
- Age range
- Over 18 Years
- Official registry ID
- ISRCTN05663421
- Official title
- A pilot study on a sensor-based Social Information Monitoring for Patients with Bipolarity (SIMBA) via smart phones
Recruitment & locations
Not recruitingGermany
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Investment & Development Bank of Lower Saxony Nbank (Germany).
Who can participate?
This study is for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
Not recruitingISRCTN68010602
Exploring the link between Bipolarity and medical diseases: an investigation of risk factors and biological characteristics for better prevention and treatment
This study is not recruiting in France, in Germany, in Italy, .... It focuses on Bipolarity.
Not recruitingEUCTR 2009-016648-38
A 6-Month, Open-Label, Flexible-Dosage (150 to 200 mg/day) Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With ...
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Not recruitingEUCTR 2009-016041-25
A Long-Term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolarity type I
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.